The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical, pathologic, and radiologic response in patients with neurofibromatosis type 2 (NF2) undergoing bevacizumab treatment.
Niamh Coleman
No relevant relationships to disclose
Megan Greally
No relevant relationships to disclose
Lynda O' Riordan
No relevant relationships to disclose
Teresa Doyle
No relevant relationships to disclose
Oscar S. Breathnach
No relevant relationships to disclose
William Grogan
No relevant relationships to disclose